Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Carmela Tan, MD

216.444.9489

Carmela Tan, MD

Appointed: 2005

Carmela Tan, MD
Department: Anatomic Pathology
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.9489
Carmela Tan, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.9489
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Carmela D. Tan, MD, is on Staff in the Department of Anatomic Pathology at Cleveland Clinic. Her interest and expertise is in the subspecialty of cardiovascular pathology. She also performs autopsy pathology.

Dr. Tan's interests include molecular diagnostics of the genetics of cardiovascular diseases.

Education & Fellowships

Fellowship - Rush Presbyterian-St. Luke's Medical Center
Cardiovascular Pathology
Chicago, IL USA
1997
Residency - Rush Presbyterian-St. Luke's Medical Center
Pathology
Chicago, IL USA
1995
Internship - Good Samaritan Hospital of Maryland
Internal Medicine
Baltimore, MD USA
1991
Medical School - University of the Philippines
Manila Philippines
1989
Undergraduate - University of the Philippines
Biology
Quezon City Philippines
1984

Certifications

  • Anatomic & Clinical Pathology

Specialty Interests

Autopsy Pathology, Cardiac Transplant Pathology, cardiovascular pathology

Awards & Honors

No

Innovations & Patents

No

Memberships

  • College of American Pathologists
  • United States and Canadian Academy of Pathology
  • American Heart Association
  • Society for Cardiovascular Pathology
  • International Society for Heart and Lung Transplantation

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/25/2014, Dr. Tan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Tagalog